transforming growth factor(alpha)-Pseudomonas exotoxin A (35)
a recombinant form of Pseudomonas exotoxin A containing TGFalpha near its carboxyl terminus for the treatment of bladder cancer; contains a modified carboxyl-terminal sequence KDEL which increases the toxin activity by 10 to 700 fold more potent than TP40 (TGFalpha-PE40)
Also Known As:
PE35-TGFalpha; PE35-TGFalpha-KDEL; TGFalpha-PE35
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results